T. Das

Adverse impact of high donor CD3+ cell dose on outcome following tandem auto-NMA allogeneic transplantation for high-risk myeloma

D. Curtis, S. Avery, A. Spencer, 2017, Bone Marrow Transplantation.

Evaluation of EuroFlow minimal residual disease measurement and donor chimerism monitoring following tandem auto-allogeneic transplantation for multiple myeloma

A. Spencer, J. Muirhead, P. Walker, 2020, Bone Marrow Transplantation.

Important factors in implementation of lineage-specific chimerism analysis for routine use

D. Kipp, D. Curtis, A. Spencer, 2020, Bone Marrow Transplantation.

Peripheral blood CD34 donor chimerism has greater clinical utility than CD3 for detecting relapse after allogeneic stem cell transplantation for AML or MDS.

D. Curtis, S. Fleming, A. Spencer, 2023, Transplantation and cellular therapy.

Cellular distribution of IDH mutations in AML during morphologic remission.

I. Tiong, A. Ivey, F. Brown, 2022, Leukemia research.